Medicare Drug Negotiations Officially Underway
February 8, 2024
On February 1, the U.S. Department of Health and Human Services (HHS) sent initial offers to manufacturers of the first
Celebrating 35 years of making Medicare more accessible, affordable, and equitable!
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
People Can Get Even More Extra Help in 2024
February 1, 2024
Beginning this year, the Inflation Reduction Act (IRA) expands eligibility for the Part D Low Income Subsidy (LIS), also called
Comments on Proposed Changes to Medicare Advantage and Part D for 2025
January 5, 2024
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
Few Beneficiaries Know Part D Out-of-Pocket Cap Now in Effect
January 4, 2024
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D
Administration Provides More Data on First 10 Drugs Subject to Price Negotiation
January 4, 2024
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of
Medicare Rights Joins Legal Fight in Defense of Drug Price Negotiation
November 16, 2023
Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by
Medicare Prescription Payment Plan (MPPP) Draft Guidance
October 25, 2023
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Medicare Prescription Payment Plan (MPPP) draft guidance. Medicare Rights is a national, nonprofit organization that works to ensure access to affordable and equitable health care for older adults and people with disabilities through counseling and advocacy, educational programs, and public policy initiatives. Each year, Medicare Rights provides services and resources to over three million people with Medicare, family caregivers, and professionals.
Government Watchdog Urges Caution and Monitoring of Part D Rebate Programs
October 19, 2023
Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of
Part D Drug Negotiations Move Forward
October 12, 2023
Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10
Medicare Drug Negotiations Officially Underway
February 8, 2024
On February 1, the U.S. Department of Health and Human Services (HHS) sent initial offers to manufacturers of the first
People Can Get Even More Extra Help in 2024
February 1, 2024
Beginning this year, the Inflation Reduction Act (IRA) expands eligibility for the Part D Low Income Subsidy (LIS), also called
Comments on Proposed Changes to Medicare Advantage and Part D for 2025
January 5, 2024
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
Few Beneficiaries Know Part D Out-of-Pocket Cap Now in Effect
January 4, 2024
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D
Administration Provides More Data on First 10 Drugs Subject to Price Negotiation
January 4, 2024
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of
Medicare Rights Joins Legal Fight in Defense of Drug Price Negotiation
November 16, 2023
Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by
Medicare Prescription Payment Plan (MPPP) Draft Guidance
October 25, 2023
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Medicare Prescription Payment Plan (MPPP) draft guidance. Medicare Rights is a national, nonprofit organization that works to ensure access to affordable and equitable health care for older adults and people with disabilities through counseling and advocacy, educational programs, and public policy initiatives. Each year, Medicare Rights provides services and resources to over three million people with Medicare, family caregivers, and professionals.
Government Watchdog Urges Caution and Monitoring of Part D Rebate Programs
October 19, 2023
Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of
Part D Drug Negotiations Move Forward
October 12, 2023
Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10